Literature DB >> 24175159

Cost-effectiveness analyses: Beauty and the beast?

Gary R Cutter1, Guoqiao Wang.   

Abstract

In this issue of Neurology® Clinical Practice, Young et al.1 discuss 5 things to consider in reading a cost-effectiveness or decision analysis study. Such studies are necessary as the medical profession wrestles with caring for patients and paying for that care. The approaches discussed by Young et al. are important to digest as this type of study will be more prevalent as pressures mount in all aspects of clinical and comprehensive care. Young et al. point out the need to interpret the models and understand the meaning of the data presented. Their article provides an excellent summary of the tools and approaches widely used by policymakers and researchers, bringing some systematic evaluation to the pressures of cost vs the benefits of therapy.

Entities:  

Year:  2013        PMID: 24175159      PMCID: PMC3806931          DOI: 10.1212/CPJ.0b013e3182a99280

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  5 in total

1.  Reading a cost-effectiveness or decision analysis study: Five things to consider.

Authors:  Kate C Young; Adam G Kelly; Robert G Holloway
Journal:  Neurol Clin Pract       Date:  2013-10

2.  Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study.

Authors:  A S C Rice; S Maton
Journal:  Pain       Date:  2001-11       Impact factor: 6.961

3.  Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.

Authors:  D S Goodin; A T Reder; G C Ebers; G Cutter; M Kremenchutzky; J Oger; D Langdon; M Rametta; K Beckmann; T M DeSimone; V Knappertz
Journal:  Neurology       Date:  2012-04-11       Impact factor: 9.910

4.  Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.

Authors:  M Rowbotham; N Harden; B Stacey; P Bernstein; L Magnus-Miller
Journal:  JAMA       Date:  1998-12-02       Impact factor: 56.272

5.  Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.

Authors:  Mike Boggild; Jackie Palace; Pelham Barton; Yoav Ben-Shlomo; Thomas Bregenzer; Charles Dobson; Richard Gray
Journal:  BMJ       Date:  2009-12-02
  5 in total
  1 in total

1.  Cost-effectiveness data: Are neurologists in practice equipped to interpret them?

Authors:  Saty Satya-Murti
Journal:  Neurol Clin Pract       Date:  2013-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.